• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice.Skp2 对于异常增殖的 Rb1 缺失细胞的存活以及 Rb1+/- 小鼠的肿瘤发生是必需的。
Nat Genet. 2010 Jan;42(1):83-8. doi: 10.1038/ng.498. Epub 2009 Dec 6.
2
Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity.Skp2 通过限制 E2F1 的活性来抑制 Rb1 缺失肿瘤中的细胞凋亡。
Nat Commun. 2014 Mar 17;5:3463. doi: 10.1038/ncomms4463.
3
p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.p27T187A基因敲入鉴定出用于晚期前列腺癌的Skp2/Cks1口袋抑制剂。
Oncogene. 2017 Jan 5;36(1):60-70. doi: 10.1038/onc.2016.175. Epub 2016 May 16.
4
Substituting threonine 187 with alanine in p27Kip1 prevents pituitary tumorigenesis by two-hit loss of Rb1 and enhances humoral immunity in old age.在p27Kip1中将苏氨酸187替换为丙氨酸可通过Rb1的双打击缺失预防垂体肿瘤发生,并增强老年个体的体液免疫。
J Biol Chem. 2015 Feb 27;290(9):5797-809. doi: 10.1074/jbc.M114.625350. Epub 2015 Jan 12.
5
Racing to block tumorigenesis after pRb loss: an innocuous point mutation wins with synthetic lethality.在 pRb 缺失后竞相阻止肿瘤发生:一种无害的点突变通过合成致死获得胜利。
Cell Cycle. 2010 Jun 1;9(11):2118-23. doi: 10.4161/cc.9.11.11726.
6
Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis.视网膜母细胞瘤1(Rb1)及其抑制靶点S期激酶相关蛋白2(Skp2)的缺失在小鼠胚胎发育过程中具有合成致死性。
J Biol Chem. 2016 May 6;291(19):10201-9. doi: 10.1074/jbc.M116.718049. Epub 2016 Mar 10.
7
Distinct outcomes from targeted perturbations of the multi-subunit SCF E3 ubiquitin ligase in blocking Trp53/Rb1-null prostate tumorigenesis.多亚基SCF E3泛素连接酶靶向扰动在阻断Trp53/Rb1基因缺失的前列腺肿瘤发生中的不同结果。
Commun Biol. 2025 Feb 22;8(1):278. doi: 10.1038/s42003-025-07662-3.
8
Targeted Inhibition of the E3 Ligase SCF Has Antitumor Activity in -Deficient Human and Mouse Small-Cell Lung Cancer.靶向抑制 E3 连接酶 SCF 在 -缺陷的人类和小鼠小细胞肺癌中具有抗肿瘤活性。
Cancer Res. 2020 Jun 1;80(11):2355-2367. doi: 10.1158/0008-5472.CAN-19-2400. Epub 2020 Apr 7.
9
Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.针对无法靶向的目标:RB1 缺陷型肿瘤易受 Skp2 泛素连接酶抑制的影响。
Br J Cancer. 2022 Oct;127(6):969-975. doi: 10.1038/s41416-022-01898-0. Epub 2022 Jun 25.
10
Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects.靶向抑制 S 期激酶相关蛋白 2(SKP2)介导的细胞周期调控在肺和其他 RB 相关癌症中的作用:对当前现状和未来前景的简要综述。
Adv Biol Regul. 2023 May;88:100964. doi: 10.1016/j.jbior.2023.100964. Epub 2023 Mar 14.

引用本文的文献

1
Cell cycle duration determines oncogenic transformation capacity.细胞周期持续时间决定致癌转化能力。
Nature. 2025 Apr 30. doi: 10.1038/s41586-025-08935-x.
2
A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins.靶向泛素连接酶以稳定肿瘤抑制蛋白的治疗前景
Cancers (Basel). 2025 Feb 13;17(4):626. doi: 10.3390/cancers17040626.
3
Distinct outcomes from targeted perturbations of the multi-subunit SCF E3 ubiquitin ligase in blocking Trp53/Rb1-null prostate tumorigenesis.多亚基SCF E3泛素连接酶靶向扰动在阻断Trp53/Rb1基因缺失的前列腺肿瘤发生中的不同结果。
Commun Biol. 2025 Feb 22;8(1):278. doi: 10.1038/s42003-025-07662-3.
4
Comprehensive single cell transcriptomics analysis of murine osteosarcoma uncovers function in metastasis, genomic instability and immune activation and reveals additional target pathways.对小鼠骨肉瘤进行的全面单细胞转录组学分析揭示了其在转移、基因组不稳定性和免疫激活方面的功能,并揭示了其他靶标通路。
bioRxiv. 2024 Jun 6:2024.06.04.597347. doi: 10.1101/2024.06.04.597347.
5
Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted Therapy.RB1基因缺陷型癌症的治疗策略:基因调控与靶向治疗的交叉点
Cancers (Basel). 2024 Apr 19;16(8):1558. doi: 10.3390/cancers16081558.
6
Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.靶向 RCC1 以阻断 Skp2 的核质转运,从而抑制人软组织肉瘤。
Cell Death Dis. 2024 Apr 1;15(4):241. doi: 10.1038/s41419-024-06629-2.
7
SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis.SKP2 敲除在骨肉瘤 Rb1/p53 缺陷型小鼠模型中诱导免疫浸润,并驱动具有有利预后的转录程序。
Mol Cancer Ther. 2024 Feb 1;23(2):223-234. doi: 10.1158/1535-7163.MCT-23-0173.
8
Inhibitors Targeting the F-BOX Proteins.靶向 F-BOX 蛋白的抑制剂。
Cell Biochem Biophys. 2023 Dec;81(4):577-597. doi: 10.1007/s12013-023-01160-1. Epub 2023 Aug 25.
9
Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.针对无法靶向的目标:RB1 缺陷型肿瘤易受 Skp2 泛素连接酶抑制的影响。
Br J Cancer. 2022 Oct;127(6):969-975. doi: 10.1038/s41416-022-01898-0. Epub 2022 Jun 25.
10
Treatment of Retinoblastoma: What Is the Latest and What Is the Future.视网膜母细胞瘤的治疗:最新进展与未来展望
Front Oncol. 2022 Apr 1;12:822330. doi: 10.3389/fonc.2022.822330. eCollection 2022.

本文引用的文献

1
Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling.视网膜母细胞瘤具有视锥前体细胞肿瘤的特性,并依赖于视锥细胞特异性的MDM2信号传导。
Cell. 2009 Jun 12;137(6):1018-31. doi: 10.1016/j.cell.2009.03.051.
2
Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.F-box蛋白SKP2和β-TrCP介导的蛋白水解失调:影响癌症的平衡
Nat Rev Cancer. 2008 Jun;8(6):438-49. doi: 10.1038/nrc2396.
3
Skp2 suppresses p53-dependent apoptosis by inhibiting p300.Skp2通过抑制p300来抑制p53依赖性凋亡。
Mol Cell. 2008 Feb 1;29(2):217-31. doi: 10.1016/j.molcel.2007.11.036.
4
A Skp2 autoinduction loop and restriction point control.一种Skp2自诱导环与限制点控制。
J Cell Biol. 2007 Aug 27;178(5):741-7. doi: 10.1083/jcb.200703034.
5
Disrupting Skp2-cyclin A interaction with a blocking peptide induces selective cancer cell killing.用阻断肽破坏Skp2与细胞周期蛋白A的相互作用可诱导选择性癌细胞杀伤。
Mol Cancer Ther. 2007 Feb;6(2):684-91. doi: 10.1158/1535-7163.MCT-06-0538.
6
Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit.视网膜母细胞瘤蛋白与后期促进复合体在细胞周期退出过程中发生物理相互作用并在功能上协同作用。
Nat Cell Biol. 2007 Feb;9(2):225-32. doi: 10.1038/ncb1532. Epub 2006 Dec 24.
7
Rb induces a proliferative arrest and curtails Brn-2 expression in retinoblastoma cells.Rb在视网膜母细胞瘤细胞中诱导增殖停滞并减少Brn-2表达。
Mol Cancer. 2006 Dec 12;5:72. doi: 10.1186/1476-4598-5-72.
8
Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer.在肺癌和结肠癌小鼠模型中检测SCFskp2途径介导的p27降解的重要性。
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14009-14. doi: 10.1073/pnas.0606316103. Epub 2006 Sep 11.
9
Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor.Nras缺失诱导Rb1缺陷型神经内分泌甲状腺肿瘤发生转移转化。
Nat Genet. 2006 Jan;38(1):118-23. doi: 10.1038/ng1703. Epub 2005 Dec 20.
10
F-box protein Skp2: a novel transcriptional target of E2F.F-box蛋白Skp2:E2F的一个新的转录靶点。
Oncogene. 2006 Apr 27;25(18):2615-27. doi: 10.1038/sj.onc.1209286.

Skp2 对于异常增殖的 Rb1 缺失细胞的存活以及 Rb1+/- 小鼠的肿瘤发生是必需的。

Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice.

机构信息

Department of Developmental and Molecular Biology and Medicine, The Albert Einstein Comprehensive Cancer Center and Liver Research Center, Albert Einstein College of Medicine, Bronx, New York, USA.

出版信息

Nat Genet. 2010 Jan;42(1):83-8. doi: 10.1038/ng.498. Epub 2009 Dec 6.

DOI:10.1038/ng.498
PMID:19966802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2990528/
Abstract

Heterozygosity of the retinoblastoma gene Rb1 elicits tumorigenesis in susceptible tissues following spontaneous loss of the remaining functional allele. Inactivation of previously studied retinoblastoma protein (pRb) targets partially inhibited tumorigenesis in Rb1(+/-) mice. Here we report that inactivation of pRb target Skp2 (refs. 7,8) completely prevents spontaneous tumorigenesis in Rb1(+/-) mice. Targeted Rb1 deletion in melanotrophs ablates the entire pituitary intermediate lobe when Skp2 is inactivated. Skp2 inactivation does not inhibit aberrant proliferation of Rb1-deleted melanotrophs but induces their apoptotic death. Eliminating p27 phosphorylation on T187 in p27T187A knock-in mice reproduces the effects of Skp2 knockout, identifying p27 ubiquitination by SCF(Skp2) ubiquitin ligase as the underlying mechanism for Skp2's essential tumorigenic role in this setting. RB1-deficient human retinoblastoma cells also undergo apoptosis after Skp2 knockdown; and ectopic expression of p27, especially the p27T187A mutant, induces apoptosis. These results reveal that Skp2 becomes an essential survival gene when susceptible cells incur Rb1 deficiency.

摘要

视网膜母细胞瘤基因 Rb1 的杂合性会在剩余功能等位基因自发丢失后引发易感组织的肿瘤发生。先前研究的视网膜母细胞瘤蛋白 (pRb) 靶点的失活部分抑制了 Rb1(+/-) 小鼠的肿瘤发生。在这里,我们报告说,pRb 靶点 Skp2 的失活(参考文献 7,8)完全阻止了 Rb1(+/-) 小鼠的自发性肿瘤发生。当 Skp2 失活时,靶向 Rb1 缺失的黑色素细胞会使整个垂体中间叶消失。Skp2 失活不会抑制 Rb1 缺失的黑色素细胞的异常增殖,但会诱导其凋亡死亡。在 p27T187A 敲入小鼠中消除 p27 在 T187 上的磷酸化可复制 Skp2 敲除的效果,确定由 SCF(Skp2) 泛素连接酶对 p27 的泛素化是 Skp2 在这种情况下发挥其重要致癌作用的潜在机制。Skp2 敲除后,RB1 缺陷型人视网膜母细胞瘤细胞也会发生凋亡;并且 p27 的异位表达,特别是 p27T187A 突变体,会诱导细胞凋亡。这些结果表明,当易感细胞发生 Rb1 缺陷时,Skp2 成为必需的存活基因。